NDC 80425-0152-01 - Pregabalin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0152
- Requested NDC
- 80425-0152-01
- Package NDCs from labels
- 80425-0152-3, 80425-0152-2, 80425-0152-1, 80425-0152-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Pregabalin - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0152-1 | Pregabalin | 30 in 1 BOTTLE | CAPSULE | 30 | 7 | |
| 80425-0152-2 | Pregabalin | 60 in 1 BOTTLE | CAPSULE | 60 | 7 | |
| 80425-0152-3 | Pregabalin | 90 in 1 BOTTLE | CAPSULE | 90 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0152 | PREGABALIN CAPSULE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 7 | Current NDC, Legacy NDC, 3 package rows | 20250101_c8acdbcf-3076-63b2-e053-2a95a90aa3c4.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0152-1 | EA - Each | 80425-0152 | 73fb64d6-4ab3-4950-abc6-83dc9526c255 | 1 | 2023-04-07 |
| 80425-0152-2 | EA - Each | 80425-0152 | dcdaf124-5c62-4490-8bc0-56dd8ba5f9bd | 1 | 2023-06-06 |
| 80425-0152-3 | EA - Each | 80425-0152 | dc199216-45d0-4937-9869-cf41aed43321 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PREGABALIN | PREGABALIN | Patrin Pharma, Inc. | d92c94e5-e542-4177-afa8-fa00ba17634c | 2022-06-21 | Warnings, Adverse reactions | 55JG375S6M |
| Pregabalin | PREGABALIN | Proficient Rx LP | 89b8c2d2-4a99-4b97-8b82-c0c36cd0df1b | 2022-06-01 | Warnings, Adverse reactions | 483448 55JG375S6M |
| Pregabalin | PREGABALIN | Proficient Rx LP | a1545bbb-b337-4760-ab4c-fb76ab019337 | 2022-05-02 | Warnings, Adverse reactions | 483450 55JG375S6M |
| Pregabalin | PREGABALIN | Proficient Rx LP | 1503dd3b-688b-4702-8fc1-954b5ffe4235 | 2022-05-02 | Warnings, Adverse reactions | 483438 55JG375S6M |
| Pregabalin | PREGABALIN | Proficient Rx LP | 9b1472ac-8b79-4f22-ae50-3b0942bd62b1 | 2022-04-01 | Warnings, Adverse reactions | 483440 483444 483442 577127 483448 483438 483450 483446 55JG375S6M |
| Pregabalin | PREGABALIN | Proficient Rx LP | d58c0808-2ff9-4ce6-9c07-56f723592385 | 2022-04-01 | Warnings, Adverse reactions | 483450 55JG375S6M |
| Pregabalin | PREGABALIN | Proficient Rx LP | a0f2b8af-0a04-4db0-adb3-d9d9369223d9 | 2022-04-01 | Warnings, Adverse reactions | 483440 55JG375S6M |
| PREGABALIN | PREGABALIN | Asclemed USA, Inc. | 69b8a843-a3a8-4d76-8418-f48288625030 | 2020-06-25 | Warnings, Adverse reactions | 483440 483444 483442 577127 483448 483438 483450 483446 55JG375S6M |
| Lyrica | PREGABALIN | Parke-Davis Div of Pfizer Inc | 60185c88-ecfd-46f9-adb9-b97c6b00a553 | 2020-06-15 | Warnings, Adverse reactions | 483440 483444 483442 577127 483448 483438 483450 483446 55JG375S6M |
| PREGABALIN | PREGABALIN | Proficient Rx LP | 4624c58f-8f77-48fa-be0f-fca4010cc8ae | 2019-10-01 | Warnings, Adverse reactions | 483438 55JG375S6M |
| PREGABALIN | PREGABALIN | Proficient Rx LP | 6022939f-92a8-4cb4-9f04-f237a4d73f6f | 2019-10-01 | Warnings, Adverse reactions | 483450 55JG375S6M |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.